Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Morning Review
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
    • Insider Transactions
  • inderesTV
  • Portfölj
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

Update on urgent capital requirements and acquisition of DecideAct A/S

Decideact
Läs börsmeddelandet

DecideAct A/S [ACT]
Company Announcement No. 01-2025

The previously announced potential acquisition continues to progress with positive dialogue between all parties. While the process has experienced some delays only due to the acquirer's compliance procedures relating to the proposed acquisition, the acquirer has confirmed their intention to finalize the transaction as soon as these matters are resolved. The expectations are that the compliance procedures will be finished, and approval given before mid-April 2025.

The acquirer has conducted due diligence and is fully aware of the Company's current position. Upon completion of the acquisition with a minimum ownership of 51%, the acquisition discussion involves substantial funding in the range of approximately $2 million to accelerate the company's growth trajectory.

While the above is very positive, the delay combined with the Company's transitions to its new business model are causing short-term liquidity challenges. Thus, Decide Act requires additional capital to support short-term operations and to achieve its path to breakeven.

Specifically, the Company requires a short-term capital injection to sustain its operations throughout March 2025. The company has for a longer period been working on capital injections from different sources. As of today, most of the opportunities are in large exhausted, but the company is though still working on some possible short term funding solutions. The company has terminated all employment contracts to minimize fixed costs going ahead and until the situation is resolved. The company will continue to work on a solution and inform the market about potential next steps in the coming weeks.

The company is aiming for a total capital injection of DKK 5 million to ensure operational continuity throughout 2025.

This press release constitutes inside information that DecideAct A/S is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was sent for publication, through the agency of the contact persons set out below, at the time stated by the Company's news distributor, Cision, at the publication of this press release.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Ta kontakt
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Om oss
  • Our team
  • Careers
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.